Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|March 23, 2019
Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancerChan Kim, Hong Jae Chon, Joo Hoon Kim, et al.
Scientific Reports|March 13, 2024
Opioid use and subsequent delirium risk in patients with advanced cancer in palliative care: a multicenter registry studyShin Hye Yoo, Jiseung Kang, Hyeon Jin Kim, et al.
Cancer Medicine|August 23, 2022
Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatmentYoung Eun Chon, Jaekyung Cheon, Hyeyeong Kim, et al.
JAMA Oncology|October 20, 2022
Association of High Levels of Antidrug Antibodies Against Atezolizumab With Clinical Outcomes and T-Cell Responses in Patients With Hepatocellular CarcinomaChan Kim, Hannah Yang, Ilhwan Kim, et al.
Surgery|November 26, 2022
Clinical feasibility of curative surgery after nab-paclitaxel plus gemcitabine-cisplatin chemotherapy in patients with locally advanced cholangiocarcinomaSung Hoon Choi, Incheon Kang, Sung Hwan Lee, et al.
Scientific Reports|May 20, 2024
Machine learning-based model to predict delirium in patients with advanced cancer treated with palliative care: a multicenter, patient-based registry cohortYu Jung Kim, Hayeon Lee, Ho Geol Woo, et al.
Biomedicines|May 25, 2024
Prognostic Significance of the Bone Marrow-to-Aorta Uptake Ratio on 2-Deoxy-2-[<sup>18</sup>F]fluoro-d-glucose Positron Emission Tomography/Computed Tomography in Patients with CholangiocarcinomaJeong Won Lee, Ik Dong Yoo, Sun-Pyo Hong, et al.
International Journal of Molecular Sciences|April 13, 2024
Prognostic Impact of Visceral Adipose Tissue Imaging Parameters in Patients with Cholangiocarcinoma after Surgical ResectionJeong Won Lee, Ik Dong Yoo, Sun-Pyo Hong, et al.
Cancers|December 11, 2022
High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell CarcinomaYun Beom Sang, Hannah Yang, Won Suk Lee, et al.
Cancer Research and Treatment|May 29, 2024
Distinct Characteristics and Changes in Liver Function of Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab for More Than 1 YearYoungun Kim, Jung Sun Kim, Beodeul Kang, et al.
Pageof 10